JP2024532780A5 - - Google Patents
Info
- Publication number
- JP2024532780A5 JP2024532780A5 JP2024508498A JP2024508498A JP2024532780A5 JP 2024532780 A5 JP2024532780 A5 JP 2024532780A5 JP 2024508498 A JP2024508498 A JP 2024508498A JP 2024508498 A JP2024508498 A JP 2024508498A JP 2024532780 A5 JP2024532780 A5 JP 2024532780A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163232983P | 2021-08-13 | 2021-08-13 | |
| US63/232,983 | 2021-08-13 | ||
| US202263317500P | 2022-03-07 | 2022-03-07 | |
| US63/317,500 | 2022-03-07 | ||
| PCT/US2022/074925 WO2023019259A1 (en) | 2021-08-13 | 2022-08-12 | Combination therapy of vps34 inhibitors and sting agonist for use in the treatment of cancer |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024532780A JP2024532780A (ja) | 2024-09-10 |
| JPWO2023019259A5 JPWO2023019259A5 (https=) | 2025-08-18 |
| JP2024532780A5 true JP2024532780A5 (https=) | 2025-08-18 |
Family
ID=83188606
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024508498A Pending JP2024532780A (ja) | 2021-08-13 | 2022-08-12 | Ｖｐｓ３４阻害剤を使用した併用療法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250127790A1 (https=) |
| EP (1) | EP4384180A1 (https=) |
| JP (1) | JP2024532780A (https=) |
| AU (1) | AU2022326573A1 (https=) |
| CA (1) | CA3228766A1 (https=) |
| TW (1) | TW202320797A (https=) |
| WO (1) | WO2023019259A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2630970A (en) * | 2023-06-15 | 2024-12-18 | Duke Street Bio Ltd | PARP1 inhibitor compounds |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015108881A1 (en) * | 2014-01-14 | 2015-07-23 | Millennium Pharmaceuticals, Inc. | Heteroaryls and uses thereof |
| DK3416957T3 (da) | 2016-02-19 | 2020-09-21 | Sprint Bioscience Ab | 6-heterocyclyl-4-morpholin-4-ylpyridin-2-on-forbindelser anvendelige ved behandlingen af cancer og diabetes |
| WO2019038387A1 (en) * | 2017-08-23 | 2019-02-28 | Sprint Bioscience Ab | PYRIDYLPYRIDONE COMPOUNDS |
| CN111094271B (zh) * | 2017-08-23 | 2023-02-28 | 思普瑞特生物科学公司 | 吡啶胺-吡啶酮化合物和嘧啶胺-吡啶酮化合物 |
| WO2020008046A1 (en) * | 2018-07-06 | 2020-01-09 | Sprint Bioscience Ab | Biomarker |
-
2022
- 2022-08-12 AU AU2022326573A patent/AU2022326573A1/en active Pending
- 2022-08-12 US US18/683,078 patent/US20250127790A1/en active Pending
- 2022-08-12 TW TW111130481A patent/TW202320797A/zh unknown
- 2022-08-12 JP JP2024508498A patent/JP2024532780A/ja active Pending
- 2022-08-12 CA CA3228766A patent/CA3228766A1/en active Pending
- 2022-08-12 EP EP22764625.4A patent/EP4384180A1/en active Pending
- 2022-08-12 WO PCT/US2022/074925 patent/WO2023019259A1/en not_active Ceased